APEXBIO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 15 Dec 2025)
What this means for you
Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88590882
- Registration number
- 6081902
- Mark type
- Stylized text
- Filed
- 23 Aug 2019
- Published for opposition
- 25 Feb 2020
- Registered
- 16 Jun 2020
- Attorney of record
- Jeannine Rittenhouse
Goods and services
- Class 005 — Pharmaceuticals: Reagent strips for medical diagnostic use; glucose control solution for medical diagnostic use; uric acid control solution for medical diagnostic use; hemoglobin testing agents for medical diagnostic use; cholesterol testing agents for medical diagnostic use; lactic acid testing agents for medical diagnostic use
- Class 010 — Medical apparatus: Testing and analytical apparatus for medical diagnostic use in the field of blood biochemistry; testing and analytical apparatus for medical diagnostic use in the field of urine biochemistry; blood uric monitoring apparatus for medical diagnostic use; blood glucose monitoring apparatus for medical use; lancets; hemoglobin testing apparatus for medical diagnostic use; cholesterol testing apparatus for medical diagnostic use; lactic acid testing apparatus for medical diagnostic use
Owner
- APEX BIOTECHNOLOGY CORPORATION, Hsinchu City, TW
- APEX BIOTECHNOLOGY CORPORATION, Hsinchu City, TW
- APEX BIOTECHNOLOGY CORPORATION, Hsinchu City, TW
Prosecution history
- 15 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 15 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 May 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Apr 2020 — USE AMENDMENT FILED
- 11 May 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 21 Apr 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Feb 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2020 — PUBLISHED FOR OPPOSITION